Although the mechanism underlying this cytokine imbalance in SGE cells of SS patients, including reduced TGFβ and increased IL-6 production is currently unknown, modulation of this imbalance may help control the chronic inflammation of the salivary glands occurring in SS patients. The gene discussed is TGFB1; the disease is synovial sarcoma.